EU Reporter has announced its commitment to support EuropaColon in its efforts to prevent colorectal cancer, with a three-year pro bono partnership to provide media and communications services to highlight the important work of colorectal cancer screening and care throughout Europe.
Speaking in Brussels at the launch of this partnership, Jola Gore Booth, founder and CEO of EuropaColon emphasized that for change to happen political will is needed.
“EuropaColon is delighted to work with EU Reporter,” said Ms Booth. “We look forward to a very rewarding three years. We believe it offers us a unique opportunity to inform all stakeholders of the importance of digestive cancers and hope this will help save lives as a result.”
EU Reporter’s owner Colin Stevens said: “I am pleased that we can help raise awareness amongst the target audience of EuropasColon. Colorectal cancer does not recognize borders, gender nor age. Everyone is potentially at risk and should have regular screening. We hope to push the work of EuropaColon up the European Political agenda so that it can gain the required political support.”
EuropaColon is an NGO committed to preventing deaths from colorectal cancer and improving the quality of life and support for those affected by the disease. It also works with key stakeholders and relevant partners to improve access to treatment and care.
In its 2017 action plan EuropaColon aims to unite patients, caregivers, healthcare professionals, politicians, the media and the public in the fight against the disease.
Its strategic objective is to expand its role as Europe’s only dedicated colorectal cancer patient advocacy umbrella organization to raise awareness of colorectal cancer and to involve and support more patients.
EU Reporter is a European multimedia news platform, providing online news and video comment on EU and world affairs in all EU official languages. Its audience is key decision-makers throughout Europe, influential thinkers, law makers, policy and business decision-makers in Brussels and national capitals.